QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

INBX

QT44Inhibrx Biosciences, Inc.
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
93.05
-1.15-1.22%
OverviewShort InterestFilings
INBXQT44Inhibrx Biosciences, Inc.·NASDAQ
OverviewShort InterestFilings
93.05-1.22%

Latest SEC Filings

Form category
Filing Date ▾Report DateFormDescriptionFilingDocument
Jun 15, 2026Jun 15, 20268-KCurrent report
Jun 04, 2026Jun 04, 20264Statement of changes in beneficial ownership
Jun 04, 2026Jun 04, 20264Statement of changes in beneficial ownership
Jun 04, 2026Jun 04, 20264Statement of changes in beneficial ownership
Jun 04, 2026Jun 04, 20264Statement of changes in beneficial ownership
May 15, 2026May 15, 2026SC 13G/ASC 13G/A
May 15, 2026May 15, 2026SC 13G/ASC 13G/A
May 14, 2026May 14, 20268-KCurrent report
May 14, 2026May 14, 202610-QQuarterly report
May 11, 2026May 11, 20268-KCurrent report
Apr 27, 2026Apr 27, 20264Statement of changes in beneficial ownership
Apr 23, 2026Apr 23, 2026DEFA14AAdditional proxy soliciting materials
Apr 23, 2026Apr 23, 2026ARSARS
Apr 23, 2026Apr 23, 2026DEF 14ADefinitive proxy statement
Apr 21, 2026Apr 21, 20268-KCurrent report
Mar 19, 2026Mar 19, 202610-KAnnual report
Mar 19, 2026Mar 19, 20268-KCurrent report
Feb 23, 2026Feb 23, 20268-KCurrent report
Feb 17, 2026Feb 17, 2026SC 13G/ASC 13G/A
Feb 11, 2026Feb 11, 2026SC 13GBeneficial ownership statement (passive)
Jan 21, 2026Jan 21, 2026SC 13GBeneficial ownership statement (passive)
Dec 16, 2025Dec 16, 20258-KCurrent report
Nov 14, 2025Nov 14, 20258-KCurrent report
Nov 14, 2025Nov 14, 202510-QQuarterly report
Oct 23, 2025Oct 23, 20258-KCurrent report
#1 / 25 of 289
Page
▼
/ 12